Preconception genetic testing should be more widely available, says UK commissionBMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2324 (Published 08 April 2011) Cite this as: BMJ 2011;342:d2324
- Susan Mayor
Preconception genetic testing for mutations that can cause genetic conditions should be made available in screening programmes to people who may benefit, the UK government’s advisory body on human genetics recommended in a report published on 6 April.
The Human Genetics Commission initiated the report in response to a request from the UK National Screening Committee for guidance on the social, ethical, and legal implications of making preconception genetic screening available across a whole population.
The two groups set up a collaborative expert working group, including representatives from the NHS sickle cell and thalassaemia screening programme and the PHG Foundation (Foundation for Genomics and Population Health), to review the issue.
“Having considered the issues associated with preconception genetic testing, in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial